FDA-iRISK New IDIQ

The contract involves the provision and development of FDA-iRISK, a sophisticated quantitative risk assessment software used by the Food and Drug Administration, its partners, and stakeholders. This software facilitates the evaluation, comparison, and prediction of the risks and severity of illnesses related to various foods, hazards, consumption patterns, and population groups. It includes internal versions specifically designed for FDA staff and external versions intended for broader stakeholder use, ensuring tailored functionality across different user groups. This ongoing indefinite-delivery, indefinite-quantity (IDIQ) contract, referenced as "FDA-iRISK New IDIQ," falls under the NAICS code 541990, which covers professional, scientific, and technical services. The contract is managed by the FDA, although specific details such as solicitation number, place of performance, and complete point of contact information are either not determined or undisclosed at this time. Interested parties can reach out to the designated acquisition liaison via email for further information, and updates or additional details will be accessible through the FDA's industry opportunity forecast portal.